喘息治療薬の世界市場2016-2020

◆英語タイトル:Global Asthma Therapeutics Market 2016-2020
◆商品コード:IRTNTR10076
◆発行会社(調査会社):Technavio
◆発行日:2016年7月27日
◆ページ数:110
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:製薬
◆販売価格オプション(消費税別)
Single User(1名利用)USD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Five User(~5名利用)USD3,000 ⇒換算¥333,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、喘息治療薬の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、市場概観、業界の構造分析、喘息治療薬の世界市場規模及び予測、種類別分析、製品別分析、投与経路(ROA)別分析、薬剤種類別分析、地域別分析/市場規模、購買基準、市場の成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About Asthma Therapeutics
Increasing allergic rhinitis is a major factor for allergic asthma leading to increase in research for the development of allergic immunotherapies for the treatment of asthma. The global asthma therapeutics market will observe a moderate growth during the forecast period because of loss of patent exclusivity of the major drugs, allowing the entry of generics into the market. This will lead to the erosion of the market share of the major asthma drugs. However, the presence of late-stage pipeline molecules will drive the market. An increase in the prevalence of asthma and the use of combination drugs will drive the growth of the market during the forecast period.

Technavio’s analysts forecast the global asthma therapeutics market to grow at a CAGR of 4.31% during the period 2016-2020.

[Covered in this report]
The report covers the present scenario and the growth prospects of the global asthma therapeutics market for 2016-2020. To calculate the market size, Technavio considers the revenue generated from the sales of brand-name, generic, and off-label drugs used for the prevention and treatment of asthma. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio’s report, Global Asthma Therapeutics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key vendors]
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GSK
• Merck

[Other prominent vendors]
• ALK-Abello
• Amgen
• Array BioPharma
• Asmacure
• Astellas Pharma
• Atopix Therapeutics
• Axikin Pharmaceuticals
• Chiesi Farmaceutici
• Dynavax Technologies Corp.
• Horizon Pharma
• Hovione Scientia
• Invion
• Ivax
• Kissei Pharmaceutical
• Kyowa Hakko Kirin
• MediciNova
• Mitsubishi Tanabe Pharma Corporation
• Mundipharma
• Nycomed
• Oxagen Limited
• Palobiofarma
• Pearl Therapeutics
• Pharmaking
• Pharmaxis
• Pulmagen Therapeutics
• Regeneron Pharmaceuticals
• Revalesio
• RSPR Pharma AB
• SAMA Pharmaceuticals
• Sanofi
• Skyepharma
• SolAeroMed
• Stallergenes
• Sterna Biologicals
• Synairgen
• Theron Pharmaceuticals
• UCB Pharma
• Vectura
• Verona Pharma
• Whanin Pharmaceutical Company

[Market driver]
• Huge market potential for mAbs
• For a full, detailed list, view our report

[Market challenge]
• Increased preference for CAM
• For a full, detailed list, view our report

[Market trend]
• Innovative technologies for drug delivery
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

※You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【レポートの目次】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Breakthrough in asthma research
• Asthma: An overview

PART 05: Pipeline portfolio

PART 06: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 07: Key buying criteria for asthma drugs

PART 08: Market segmentation by type of treatment
• Preventive medications
• Quick-relief medications
• Others

PART 09: Market segmentation by drug class
• Combination therapies
• Bronchodilators
• Immunosuppressants
• Leukotriene antagonists
• Mast cell stabilizers

PART 10: Segmentation by route of administration
• Inhalation
• Parenteral
• Oral

PART 11: Drug delivery devices market for asthma drugs
• Market overview
• Market segmentation by product type

PART 12: Geographical segmentation
• Global asthma therapeutics market by geography 2015-2020
• Asthma therapeutics market in Americas
• Asthma therapeutics market in EMEA
• Asthma therapeutics market in APAC

PART 13: Market drivers
• Huge market potential for mAbs
• New product approvals minimizing the impact of generic erosion
• Increasing rate of allergies due to environmental pollution

PART 14: Impact of drivers

PART 15: Market challenges
• Increased preference for CAM
• Poor patient adherence toward controller medications
• Presence of different phenotypes of asthma leading to prescription errors

PART 16: Impact of drivers and challenges

PART 17: Market trends
• Innovative technologies for drug delivery
• Growing adoption of immunotherapies
• Shift toward immune/inflammatory system targets from glucocorticoid and adrenergic receptors
• Increase in online marketing services
• Growing use of home healthcare devices

PART 18: Vendor landscape
• Competitive scenario
• Key news

PART 19: Key vendor analysis
• AstraZeneca
• Boehringer Ingelheim
• F. Hoffmann-La Roche
• GSK
• Merck
• Other prominent vendors

PART 20: Appendix
• List of abbreviations

PART 21: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Breakthrough in asthma research
Exhibit 03: Major diagnostic procedures for asthma
Exhibit 04: Percentage share of pipeline molecules based on stage of development
Exhibit 05: Pipeline portfolio: Global asthma therapeutics market
Exhibit 06: Global asthma drugs market: Market overview 2015
Exhibit 07: Global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 08: Global asthma drugs market snapshot: Developed and emerging markets 2015
Exhibit 09: Global asthma therapeutics market: Key parameters driving the market growth 2015
Exhibit 10: Five forces analysis
Exhibit 11: Key buying criteria for asthma drugs
Exhibit 12: Global asthma therapeutics market: Key parameters importance
Exhibit 13: Impact of key customer segments on market
Exhibit 14: Segmentation of asthma drugs based on type of treatment
Exhibit 15: Segmentation of asthma drugs based on drug class
Exhibit 16: Percentage share of global asthma therapeutics by drug class based on revenue 2015
Exhibit 17: Global asthma therapeutics market: Drug class segmentation growth cycle analysis 2015
Exhibit 18: Combination therapies market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 19: Bronchodilators market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 20: Percentage share of allergy immunotherapies and steroids in global immunosuppressants market 2015
Exhibit 21: Immunosuppressants market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 22: Leukotriene antagonists market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 23: Mast cell stabilizers market in global asthma therapeutics market 2015-2020 ($ billions)
Exhibit 24: Segmentation of global asthma therapeutics market by route of administration
Exhibit 25: Global asthma drug delivery devices market 2015-2020 ($ millions)
Exhibit 26: Global asthma drug delivery devices market segmentation by product type
Exhibit 27: Percentage share of global asthma drug delivery devices by type 2015
Exhibit 28: Percentage share of inhalers in global asthma drug delivery devices market 2015
Exhibit 29: Inhalers market in global asthma drug-delivery devices market 2015-2020 ($ millions)
Exhibit 30: Percentage share of nebulizers in global asthma drug delivery devices market 2015
Exhibit 31: Nebulizers market in global asthma drug-delivery devices market 2015-2020 ($ millions)
Exhibit 32: Global asthma therapeutics market by geography 2015-2020
Exhibit 33: Percentage share of global asthma therapeutics market by geography 2015 and 2020
Exhibit 34: Global asthma therapeutics market segmentation by geography 2015-2020 ($ billions)
Exhibit 35: Global share of asthma therapeutics market by geography 2015
Exhibit 36: Global asthma therapeutics market: Country analysis based on revenue and growth rate
Exhibit 37: Impact of ACA act on asthma therapeutics market
Exhibit 38: Asthma therapeutics market in Americas 2015-2020 ($ billions)
Exhibit 39: Asthma therapeutics market: PEST analysis
Exhibit 40: Prevalence of asthma in major countries of EMEA
Exhibit 41: Asthma therapeutics market in EMEA 2015-2020 ($ billions)
Exhibit 42: Asthma therapeutics market in EMEA: PEST analysis
Exhibit 43: Asthma therapeutics market in APAC 2015-2020 ($ billions)
Exhibit 44: Asthma therapeutics market: PEST analysis
Exhibit 45: mAbs approved for treatment of asthma
Exhibit 46: mAbs under development for treatment of asthma
Exhibit 47: Impact of drivers
Exhibit 48: Use of CAM therapies among individuals in US
Exhibit 49: Impact of drivers and challenges
Exhibit 50: Market share of major vendors based on asthma therapeutics revenue 2015
Exhibit 51: Competitive scenario of global asthma therapeutics market vendors 2015-2020
Exhibit 52: Geographical presence of key vendors
Exhibit 53: AstraZeneca: YoY revenue and growth rate of Symbicort 2013-2015 ($ billions)
Exhibit 54: AstraZeneca: Geographical segmentation of Symbicort 2015
Exhibit 55: AstraZeneca: YoY revenue and growth rate of Pulmicort 2013-2015 ($ millions)
Exhibit 56: AstraZeneca: Geographic segmentation of Pulmicort 2015
Exhibit 57: AstraZeneca: Metrics analysis
Exhibit 58: Boehringer Ingelheim: YoY revenue and growth rate of Spiriva 2013-2015 ($ billions)
Exhibit 59: Boehringer Ingelheim: Metrics analysis
Exhibit 60: F. Hoffmann-La Roche: YoY revenue and growth rate of Xolair 2012-2014 ($ millions)
Exhibit 61: F. Hoffmann-La Roche: Metrics analysis
Exhibit 62: GSK: YoY revenue and growth rate of Seretide/Advair 2013-2015 ($ billions)
Exhibit 63: Geographical segmentation of Seretide/Advair 2015
Exhibit 64: GSK: YoY revenue and growth rate of Flixotide/Flovent 2013-2015 ($ billions)
Exhibit 65: GSK: Geographical segmentation of Flixotide/Flovent 2015
Exhibit 66: GSK: YoY revenue and growth rate of Ventolin 2013-2015 ($ billions)
Exhibit 67: GSK: Geographical segmentation of Ventolin 2015
Exhibit 68: GSK: YoY growth and revenue of Relvar/Breo Ellipta 2014-2015 ($ millions)
Exhibit 69: GSK: Geographical segmentation of Relvar/Breo Ellipta 2015
Exhibit 70: GSK: Metrics analysis
Exhibit 71: Merck: YoY growth and revenue of Singulair 2013-2015 ($ millions)
Exhibit 72: Merck: YoY growth and revenue of Dulera 2013-2015 ($ millions)
Exhibit 73: Merck: Metrics analysis0



【掲載企業】

AstraZeneca, Boehringer Ingelheim, F. Hoffmann-La Roche, GSK, Merck, ALK-Abello, Amgen, Array BioPharma, Asmacure, Astellas Pharma, Axikin Pharmaceuticals, Chiesi Farmaceutici, Dynavax Technologies, Horizon Pharma, Hovione Scientia, Invion, Ivax, Kissei Pharmaceutical, Kyowa Hakko Kirin, MediciNova, Mitsubishi Tanabe Pharma, Mundipharma, Nycomed, Oxagen Limited, Palobiofarma, Pearl Therapeutics, Pharmaking, Pharmaxis, Pulmagen Therapeutics, Regeneron Pharmaceuticals, Revalesio, RSPR Pharma AB, SAMA Pharmaceuticals, Sanofi, Skyepharma, SolAeroMed, Stallergenes, Sterna Biologicals, Synairgen, Theron Pharmaceuticals, UCB Pharma, Vectura, Verona Pharma, Whanin Pharmaceutical.

【レポートのキーワード】

アレルギー性鼻炎、喘息、喘息薬、喘息治療、喘息予防

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[喘息治療薬の世界市場2016-2020]販売に関する免責事項
★調査レポート[喘息治療薬の世界市場2016-2020]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆